Imatinib mesylate-induced interstitial lung disease in a patient with prior history ofMycobacterium tuberculosisinfection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib mesylate-induced interstitial lung disease in a patient with prior history ofMycobacterium tuberculosisinfection

Published:2015 Issue:4 Volume:30 Page:550
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Lee Na-Ri¹²,Jang Ji Won¹,Kim Hee Sun³,Yhim Ho-Young¹²

Affiliation:

1. Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea.

2. Research Institute of Clinical Medicine, Chonbuk National University Hospital, Jeonju, Korea.

3. Department of Nursing, Wonkwang University School of Medicine, Iksan, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2015.30.4.550

Reference5 articles.

1. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate

2. Imatinib Mesylate-Induced Interstitial Pneumonitis

3. Challenging Problems in Advanced Malignancy

4. Drug-induced and iatrogenic infiltrative lung disease

5. Chronic obstructive pulmonary disease in non-smokers

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment dilemmas in patients with gastrointestinal stromal tumors (GIST) who experienced imatinib-induced pneumonitis: A case series;Current Problems in Cancer: Case Reports;2024-03

2. Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia;Journal of Oncology Pharmacy Practice;2020-12-29

3. Imatinib-induced interstitial pneumonitis – a literature review and case report;Journal of Mind and Medical Sciences;2020-04-04

4. Effects of host‐directed therapies on the pathology of tuberculosis;The Journal of Pathology;2020-03-24

5. Update on the management of chronic myeloid leukemia: current best practice and future directions;Expert Opinion on Orphan Drugs;2019-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3